Digene Founder Headed for the Windy City

Here's a name from the past: Floyd Taub.
He founded Digene, a Gaithersburg biotech company that was recently bought by Qiagen for about $1.6 billion. Taub hadn't been involved in Digene for some time, but just now I got word out of Chicago -- my hometown -- that Taub has turned up as chief executive of a company there called CytoCore.

CytoCore, a privately held startup, is working on developing products for cancer screening and diagnosis. For more information about the company, click here.
---Michael Rosenwald

By Mike Shepard  |  July 12, 2007; 12:58 PM ET
Previous: Poultry Producer Adding 750 Jobs | Next: Sunrise Senior Living's Outlines Acting CFO's Pay

Comments

Please email us to report offensive comments.



Yes Dr Taub has another little Hidden Gem on his hands.

Posted by: Roger | July 12, 2007 11:49 PM

CytoCore is a public company trading on the OTC.BB with a ticker symbol of CYCR.OB

Posted by: Roger | July 12, 2007 11:59 PM

CytoCore is a diamond in the rough - to manage to attract Dr. Taub tells the story!

Might be worth investing as long as it's below a buck!

Posted by: Doffen | July 13, 2007 12:25 PM

Cytocore has a long way to go - However, Dr. Taub has a good reputation to bring the products to the market - and when this will happen - CYCR is a great investment opportunity

Posted by: Arno | July 24, 2007 1:38 PM

The comments to this entry are closed.

 
 
RSS Feed
Subscribe to The Post

© 2010 The Washington Post Company